基因编辑市场按产品、技术、应用、最终用户和地区划分

基因编辑市场预计在 2025 年达到 48 亿美元，预计到 2032 年将达到 95.1 亿美元，2025 年至 2032 年的复合年增长率为 10.2%。

基因编辑是一种基因工程技术，它允许对生物体的DNA进行标靶修改。技术进步显着提高了基因编辑的范围和效率，为治疗性基因修饰和性状改良提供了经济高效的选择。全球基因编辑市场涵盖了与基因组编辑相关的工具、产品和服务，应用于各种研究、治疗和农业领域。过去十年，基因编辑已发展成为最尖端科技，可用于疾病治疗和农业。随着精准性、安全性和递送方法的不断改进，基因编辑有望颠覆现有产业，并革新现代生物技术。

市场动态

全球基因编辑市场的发展主要得益于来自公共和私人机构对生物技术研发投入的不断增长。包括CRISPR-Cas9在内的基因编辑工具的进步，正在拓展其潜在的治疗应用，并推动市场成长。定序和合成成本的降低也促进了基因编辑技术的普及。然而，基因编辑作物和治疗产品的商业化仍面临监管方面的挑战，这在一定程度上限制市场成长。此外，缺乏成熟的递送方法和脱靶编辑问题仍然是主要挑战。体内递送系统的开发为拓展至新的疾病治疗领域提供了机会。农业领域的成功商业性应用也预示着基因编辑技术具有良好的长期前景。

本报告的主要特点

• 本报告对全球基因编辑市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。
• 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
• 全球基因编辑市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告提供的见解将使负责人和公司经营团队能够就未来的产品发布、产品更新、市场扩张和行销策略做出明智的决策。
• 《全球基因编辑市场》报告面向该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过各种用于分析全球基因编辑市场的策略矩阵，更轻鬆地做出决策。

目录

第一章 分析目标与先决条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监理及趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 监管情景
  • 产品上市/核准
  • PEST分析
  • 波特五力分析
  • 企业合併情景
  • 产业趋势

4. 全球基因编辑市场（依产品划分）（2020-2032 年）

• 成套工具
• 试剂
• 软体

5. 全球基因编辑市场依技术划分（2020-2032 年）

• CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
• TALEN (Transcription Activator-Like Effector Nuclease)
• ZNF (Zinc Finger Nucleases)
• Meganucleases
• Prime Edit
• 其他（搭便车等）

6. 全球基因编辑市场依应用领域划分（2020-2032 年）

• 细胞株工程
• 基因工程
• 药物发现
• 临床诊断
• 异种移植
• 农业

7. 全球基因编辑市场（依最终用户划分）（2020-2032 年）

• 製药和生物技术公司
• 学术和研究机构
• CRO（委外研发机构）
• 诊断公司
• 其他的

8. 全球基因编辑市场区域划分（2020-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第九章 竞争情势

• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• Horizon Discovery
• Sangamo Therapeutics
• Cellectis
• Genomatix
• Integrated DNA Technologies
• New England Biolabs
• Takara Bio
• Bio-Rad Laboratories
• Ginkgo Bioworks

第十章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map (COM)

第十一章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Gene Editing Market is estimated to be valued at USD 4.80 Bn in 2025 and is expected to reach USD 9.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.

Gene editing is a type of genetic engineering which allows targeted changes to be made to an organism's DNA. Technologies, have greatly expanded the scope and efficiency of gene editing by providing cost-effective options for therapeutic modifications and trait improvements. The global gene editing market encompasses tools, products, and services related to gene editing of genomes in various research, therapeutic, and agricultural applications. Over the past decade, gene editing has become a frontier technology with significant potential for disease treatment and agriculture. With continued improvements in precision, safety, and delivery methods, is anticipated to disrupt established industries and transform modern biotechnology.

Market Dynamics

The global gene editing market is driven by growing investments in biotechnology research and development from both private and public sources. Advancements in CRISPR-Cas9 and other gene editing tools have expanded the potential for therapeutic applications, boosting market growth. Reduced costs of sequencing and synthesis are also improving access to gene editing technologies. However, regulatory concerns around the commercialization of gene edited crops and therapeutic products continue to restrain market growth. Additionally, lack of established delivery methods and off-target editing remain major challenges. The development of in vivo delivery systems presents an opportunity for expansion into new disease treatment areas. Successful commercial applications in agriculture also present a promising prospect over the long term.

Key Features of the Study

• This report provides in-depth analysis of the global gene editing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gene editing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Horizon Discovery, Sangamo Therapeutics, Cellectis, Genomatix, Integrated DNA Technologies, New England Biolabs, Takara Bio, Bio-Rad Laboratories, and Ginkgo Bioworks
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gene editing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene editing market

Market Segmentation

• Product Insights (Revenue, USD Bn, 2025 - 2032)
  • Kits
  • Reagents
  • Software
• Technology Insights (Revenue, USD Bn, 2025 - 2032)
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Transcription Activator-Like Effector Nuclease (TALEN)
  • ZFN (Zinc Finger Nucleases)
  • Meganucleases
  • Prime Editing
  • Others (PiggyBac, etc.)
• Application Insights (Revenue, USD Bn, 2025 - 2032)
  • Cell Line Engineering
  • Genetic Engineering
  • Drug Discovery
  • Clinical Diagnostics
  • Xenotransplantation
  • Agriculture
• End User Insights (Revenue, USD Bn, 2025 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Diagnostic Companies
  • Others
• Regional Insights (Revenue, USD Bn, 2025 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Horizon Discovery
  • Sangamo Therapeutics
  • Cellectis
  • Genomatix
  • Integrated DNA Technologies
  • New England Biolabs
  • Takara Bio
  • Bio-Rad Laboratories
  • Ginkgo Bioworks

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Gene Editing Market, By Product
  • Global Gene Editing Market, By Technology
  • Global Gene Editing Market, By Application
  • Global Gene Editing Market, By End User
  • Global Gene Editing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Gene Editing Market, By Product, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Gene Editing Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transcription Activator-Like Effector Nuclease (TALEN)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• ZFN (Zinc Finger Nucleases)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Meganucleases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prime Editing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (PiggyBac, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Editing Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cell Line Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Xenotransplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Agriculture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Editing Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Editing Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• CRISPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Editas Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Intellia Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Horizon Discovery
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sangamo Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cellectis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genomatix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Integrated DNA Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ginkgo Bioworks
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us